机译:P2.01-86具有脑转移脑转移的ALK阳性肺癌中来自脑脊液和血浆的循环无细胞DNA的遗传分析
Medical Oncology Beijing Chest Hospital capital Medical University;
Medical Oncology Beijing Chest Hospital capital Medical University;
Medical Oncology Beijing Chest Hospital capital Medical University;
Medical Oncology Beijing Chest Hospital capital Medical University;
Medical Oncology Beijing Chest Hospital capital Medical University;
Medical Oncology Beijing Chest Hospital capital Medical University;
Medical Oncology Beijing Chest Hospital capital Medical University;
Medical Oncology Beijing Chest Hospital capital Medical University;
Medical Oncology Beijing Chest Hospital capital Medical University;
Medical Oncology Beijing Chest Hospital capital Medical University;
Medical Oncology Beijing Chest Hospital capital Medical University;
Medical Oncology Beijing Chest Hospital capital Medical University;
Medical Oncology Beijing Chest Hospital capital Medical University;
机译:P2.01-86具有脑转移脑转移的ALK阳性肺癌中来自脑脊液和血浆的循环无细胞DNA的遗传分析
机译:OA 10.02独特的遗传型材,来自EGFR突变体NSCLC的百分之肌雌性转移中脑脊液的无细胞DNA
机译:由脑肺癌患者的脑脊髓液无细胞DNA获得独特的基因组曲线,含有百分症转移
机译:循环无细胞的DNA基QMSP证明了Sydecan2甲基化作为有望的表观遗传生物标志物,用于早期检测患癌前和癌细胞病患者的患者
机译:使用临床病理分析和基因谱分析将同期的第二原发性肺癌与肺转移瘤区分开来。
机译:案例报告:通过脑脊髓循环肿瘤DNA检测的遗传测序vemurafenib治疗BRAFS365L-突变肺乳头状癌的脑转移
机译:案例报告:通过脑脊髓循环肿瘤DNA检测的遗传测序,vemurafenib治疗BRAFS365L-突变肺乳头状癌的脑转移